New research from the USA, published in the Equine Veterinary Journal (EVJ), has shown that a toxin from the box elder tree is the likely cause of Seasonal Pasture Myopathy (SPM), the US equivalent of the European disease known as Atypical Myopathy (AM).
According to the British Equine Veterinary Association, preliminary comparisons of these results with cases of AM in Europe suggest that the European condition may be linked to similar trees which could have an important bearing on the future prevention of the disease in Europe.
Seasonal Pasture Myopathy is a highly fatal muscle disease in Midwestern USA and Eastern Canada. A similar disorder called Atypical Myopathy is becoming increasingly frequent in the UK and Northern Europe. Outbreaks of both diseases tend to be seasonal, with most cases occurring in the autumn. Horses that develop SPM and AM are usually kept in sparse pastures with an accumulation of dead leaves dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
The research1 identified that seeds from box elder trees were consistently present in the autumn pastures of all 12 horses enrolled in the study. These horses were from 11 different farms and had all presented with the clinical signs of SPM, which include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle trembling. The toxic amino acid hypoglycin A, which is known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD) was shown to be present in the box elder seeds and hypoglycin metabolites were identified in the serum or urine of all the horses. All but one of the cases proved fatal.
Professor Valberg DVM PhD of the Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, who instigated the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses. We are intending to conduct further studies to determine the factors that affect the highly variable hypoglycin A concentrations in box elder seeds."
Professor Valberg has established collaborative links with groups in Europe in order to investigate if a similar toxin is involved in European Atypical Myopathy. Working with Professor Vince Gerber and Dr Lucia Unger at the University of Bern, Professor Valberg has obtained seeds from a tree related to the Box Elder found on many pastures where Atypical Myopathy has occurred.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is a really important step forwards. We don't yet know for sure that the cause of European disease, Atypical Myopathy, is the same as Seasonal Pasture Myopathy in the US. But the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate. It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect."
1 Seasonal Pasture Myopathy/Atypical Myopathy in North America associated with Ingestion of Hypoglycin A within Seeds of the Box Elder Tree Stephanie J Valberg DVM PhD1, Beatrice T Sponseller Dr. med. vet2, Adrian D Hegeman PhD3, Jennifer Earing PhD, Jeffery B. Bender DVM MS1, Krishona L Martinson PhD4, Steven E Patterson PhD5, Lawrence Sweetman PhD1
Would-be candidates in the Royal College of Veterinary Surgeon Council and Veterinary Nurse Council elections are reminded that the nominations deadline is 5pm on 31 January 2013.
Veterinary surgeons need two nominations from veterinary surgeons, and veterinary nurses two nominations from veterinary nurses, to stand in the respective elections.
Veterinary surgeons and veterinary nurses not presently on either Council can nominate one candidate each.
Nomination forms, full instructions and guidance notes are available from www.rcvs.org.uk/rcvscouncil13 and www.rcvs.org.uk/vncouncil13.
Six seats are due to be filled on RCVS Council, and two on VN Council. Those elected will take their seats on RCVS Day next July, to serve four-year terms. Council members will be expected to spend at least six to eight days a year attending Council and Committee meetings, working parties and subcommittees (for which a loss-of-earnings allowance is available).
The Animal Welfare Foundation (AWF) has unveiled a new brand identity and fresh new website design to kick-start its 30th anniversary celebrations.
According to the charity, market research had shown that most respondents thought its old logo was unrecognisable. The new one aims to strengthen the charity's identity by making it more visually appealing and by representing the wide range of species the charity covers in its research funding, information leaflets and its advice to vets.
The new website remains at www.bva-awf.org.uk and combines the new logo with a fresh design to help guide vets, researchers and the public to the relevant resources and information quickly.
New features include a revised grants section which now includes a list of past and present projects and advice to guide potential grants recipients through the application process. To emphasise the Foundation's reliance on donations and legacies the donation button has been made more prominent and the new site also contains case studies which help veterinary students work through welfare dilemmas.
The charity's unique selling point and strapline 'The charity led by the veterinary profession' is also clearly displayed to further strengthen the AWF brand.
AWF Chair Dr Tiffany Hemming said: "We have tried to make the site as appealing, well-structured and easy to navigate as possible to show off all our areas of activity and to encourage use of our excellent resources.
"In the year of our 30th anniversary I am pleased to have this fresh new image to help us stay in people's minds where animal welfare is concerned, whether it is a veterinary practice wanting to provide clients with easy-to-understand leaflets, a researcher looking for funding or a member of the public who has heard of our initiatives and resources.
"We have more exciting plans in the pipeline to celebrate AWF at 30 so visit the website and look out for more information."
BVA President Peter Jones added: "With a strong new brand and website I hope AWF becomes an increasingly popular destination for vets in particular and for the general public with its simple and practical advice for everyone concerned with animal welfare.
"I also hope that the profession will find renewed enthusiasm for its own animal welfare charity which needs to attract donations to continue its work to promote animal welfare through research, education and debate."
Petplan has launched what it says is the biggest advertising campaign in its 36-year history.
The company won't reveal what it's spending on the campaign, but its built around a TV advert (below) being shown on all the major channels throughout January, so certainly a bob or two. The ad features 45 different breeds of cats, dogs and rabbits - representing some of the breeds Petplan has insured over the years.
Simon Masding, head of sales and partnerships at Petplan said: "As the UK market leader, it is imperative pet owners recognise and understand who we are and what we stand for. We want to help our partners educate pet owners not only why pet insurance is so important, but explain why they should choose Petplan over any other provider. In 36 years, there's not an illness or accident that we haven't seen and our new advert dramatises in a charming way the depth and breadth of our breed and claims experience".
As part of the campaign, Petplan is running a 'Guess the Breed' game: correctly identify 10 of the breeds featured and be in with the chance to win a Petplan gilet. To enter, visit www.petplanvet.co.uk
The RCVS has launched a newsletter for those involved with veterinary nurse education and training.
The title - VN Education - replaces VN Standard, the newsletter from RCVS Awards, the College's awarding body. It focuses on the regulatory aspects of all veterinary nurse education, including both vocational and undergraduate training.
Libby Earle, RCVS Head of Veterinary Nursing said: "The new title marks a change in focus, as we wind down the RCVS awarding body and withdraw from awarding vocational qualifications.
"Our core focus is now the quality assurance of all those qualifications leading to registration with the RCVS, and VN Education aims to keep people up to date on regulatory and quality assurance issues."
VN Education will be published three times a year to those involved in veterinary nurse education, and can also be downloaded from www.rcvs.org.uk/publications. The first issue will be distributed towards the end of January.
4,661 veterinary surgeons voted, the highest turnout seen in ten years. 1,329 veterinary nurses voted, the highest ever number.
Veterinary surgeons voted incumbents Christopher Gray, Peter Jinman, Bradley Viner, Christopher Tufnell, and Jeremy Davies back onto the RCVS Council. However, the highest number of votes was given to Thomas Witte, who will be new to Council when he takes his seat in July. Veterinary nurses voted similarly by returning Andrea Jeffery to VN Council, whilst giving to Amy Robinson, another newcomer, the largest number of votes.
According to the College, turnout in both elections has increased markedly on last year in both absolute and proportional terms. Votes were cast by 4,661 veterinary surgeons (18.8%) and 1,329 veterinary nurses (12.5%), compared to 3,625 (15.1%) and 743 (7.5%), respectively, in 2012.
Gordon Hockey, RCVS Registrar said: "We're delighted with the increase in turnout. It's difficult to pinpoint the reasons for the increase, but hopefully, it's because increasing numbers of vets and nurses are feeling more engaged with the College. We have also undertaken extra communications activities this year, such as the 'hustings', which we hope have helped."
The Council election 'hustings' was a new venture this year, with RCVS Council candidates able to select three questions, submitted by voters, to answer in a live webinar run by The Webinar Vet.
Veterinary surgeons and VNs could cast their votes by post, online, or by text. The majority of vets voting chose to cast postal votes (3,247), as did the majority of VNs (1,055). Whilst voting online was used by 1,330 veterinary surgeons, only 227 VNs chose it as a means of voting. Voting by text was used by only 84 veterinary surgeons and 47 VNs.
The successful candidates will take up or resume their seats at RCVS Day on 5 July.
The full results of the two elections are as follows:
RCVS Council electionWITTE, Thomas Hermann - 2,251 (Elected)GRAY, Christopher John - 1,974 (Elected)JINMAN, Peter Charles - 1,949 (Elected)VINER, Bradley Phillip - 1,927 (Elected)TUFNELL, Christopher Wynne - 1,883 (Elected)DAVIES, Jeremy Vincent - 1,830 (Elected)STURGESS, Christopher Paul - 1,809 CONNELL, Niall Thomas - 1,596 ROBINSON, Peter Bayley - 1,366 ELLIS, Robert Nigel Ward - 1,302 GRANT, Lewis George - 832 TORGERSON, Paul Robert - 824 LONSDALE, Thomas - 337 Twenty-two votes in the RCVS Council election were found to be invalid.VN Council election
ROBINSON, Amy - 725 (Elected)JEFFERY, Andrea Karen - 607 (Elected)BADGER, Susan Frances - 459TOTTEY, Helen Wendy 332 One vote in the VN Council election was found to be invalid.The 2013 RCVS and VN Council elections were run on behalf of the RCVS by Electoral Reform Services.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
Bayer Animal Health, maker of Tracer microchips, has produced a new video in which Emma Milne and Petlog Executive Celia Walsom consider the implications for practices of the change in the law which will make it compulsory for all dogs to be microchipped from April 2016.
The 15-minute video considers various issues, such as:
The College of Animal Welfare has opened a business school at its training and education centre in Chord Business Park in Godmanchester.
CAW Business School provides accountancy courses accredited by the Association of Accounting Technicians (AAT) and leadership and management courses accredited by the Institute of Leadership and Management (ILM).
Leslie Heaton Smith, Director at The College of Animal Welfare, said: "The opening of our Business School is a new development in a long line of achievements and marks an exciting new venture. Whilst our focus has always been towards developing technical animal and veterinary related knowledge and skills to make significant improvements in animal welfare and veterinary care, we also recognise that quality of care is also highly dependent on the management and leadership of those controlling and investing the organisation's often scarce resources. Thus in order to provide high quality welfare to animals entrusted into their care, organisations need to be able to employ people with such skills".
The leadership and management courses are already underway and can be studied entirely online, or online with study weekends.
The College says the majority of AAT courses will start in September 2013, however an 8 week Level 2 Certificate in Bookkeeping course starts at the beginning of June. The College is also an AAT approved exam centre, meaning that students can sit their exams whilst at college.
For further information, call the College on 01480 422060 and speak to one of the Business School tutors. Alternatively, visit www.caw.ac.uk or book a place on the next open day on Wednesday 22 May from 9am-12pm or 6-9pm.
The American Kennel Club Canine Health Foundation has awarded Dr. Bruce Smith, director of the Auburn University Research Initiative in Cancer, a two-year grant totaling $118,848 to test a new therapy for treating bone cancer in dogs.
According to the University, the research could one day be broadened to include many other kinds of cancer - and possibly cancer in people.
The treatment consists of a virus normally used as a hepatitis vaccine in dogs that has been modified to only make copies of itself inside bone cancer cells. The virus ruptures the cancer cells, releasing thousands of copies of the virus from the tumor cells, killing them.
Dr. Smith said: "By using this approach, we turn the cancer cell into a 'factory' that produces more virus. You could say that we help the cancer cell become an agent of its own death."
Bone cancer, or osteosarcoma, accounts for around 5% of tumours in dogs. More than 90% of dogs with this tumour have had tumour cells migrate into their lungs, creating what are known as micrometastases, at the time of diagnosis.
Dr. Smith said: "This therapy attacks those metastases and will hopefully eliminate them or make them more sensitive to chemotherapy."
The Auburn University Research Initiative in Cancer, or AURIC, was founded in 2012 to accelerate translation of cancer innovation from the laboratory to the clinic. AURIC embodies "One Medicine" - the concept that sees human and animal health as a single field where discoveries in one species advance health in both species.
Fitzpatrick Referrals has launched a new sports medicine and rehabilitation centre for dogs at its referral centre in Surrey.
Fitzpatrick Referrals has been running a dedicated rehabilitation centre since the practice opened at Eashing in 2007. It has now extended the offering to include sports medicine clinics and osteoarthritis clinics, creating what it claims is the largest centre of its kind in the country.
Building work has now been completed at the centre and Fitzpatrick Referrals has appointed David Prydie MRCVS, a small animal rehabilitation expert, to head up the centre.
Speaking about the launch of the new service, Noel Fitzpatrick, Managing Director of Fitzpatrick Referrals said: "At Fitzpatrick Referrals, we believe that appropriate rehabilitation is integral to the success of orthopaedic and neuro-surgical intervention and fundamental in promoting pain free functional quality of life.
"Traditionally, the rehabilitation centre has been geared towards treating post-op patients. While the new centre will continue to treat animals which have been referred to Fitzpatrick Referrals for surgical procedures, helping to restore function, reduce pain and speed up the recovery process, we will now offer new dedicated Sports Medicine and Osteoarthritis clinics, of which there are currently only a handful in the UK. This will provide referring practitioners and clients with a new range of options for dealing with sports injuries and the on-going management of Osteoarthritis.
"For the first time, minimally invasive arthroscopic investigation and advanced diagnostic imaging with MRI and CT will be available side-by-side with a team of clinicians who truly understand the unique anatomy, physiology and exercise demands of working and sports dogs and who adopt an integrated approach to achieving maximum mobility for dogs of all ages. We intend that the new centre will create a new standard of integrated care for the active performance or pet dog because we will match function with form and intention with action. Every plan will be tailor made for the individual with sincere attention to the very special environment and demands of the sporting dog. I'm extraordinarily excited about this new horizon."
David Prydie added: "We expect to see cases where there are specific injuries which the canine athlete is prone to and which require specialist knowledge to identify and treat. Our goal is to help the dogs return to their performance event as soon as possible. We will also be offering advice on training regimes for the various activities. The centre will offer a new osteoarthritis clinic, treating osteoarthritis in all ages of dog using a multimodal approach such as weight management, exercise regimes, physiotherapy techniques and use of tools such as the therapeutic laser. There is a wealth of experience already present within the practice and I will be working with Noel and the other surgeons to develop our offering in sports injury management and also with Professor Stuart Carmichael in the development of osteoarthritis management schemes."
The practice will celebrate the launch of the new centre with its first festival for pets, 'Dogfest', built around the theme of the 'Active Dog'. The festival will take place on 10th and 11th of August and will feature a number of agility and flyball events, canine sports medicine lectures delivered by world experts, a range of tents and stalls, 'Have a Go' agility sessions, an agility display by former Fitzpatrick patients who have returned to compete in the agility circuit, a 'Meet the Fitzpatrick Heroes' display and a special '999' display by the Sussex Police Dogs on both days.
For information on the new Fitzpatrick Sports Medicine and Rehabilitation Centre services and to discuss referrals, contact the reception team on 01483 423 761.
Each candidate will produce a written reply to two questions of their choice, which will be included on their candidate profile webpage ahead of the start of the election.
The three candidates who are standing in this year’s election for the two available elected places on VN Council are:
The VN Council candidate biography and statements are available to read on www.rcvs.org.uk/vnvote24
The two candidates with the most votes will join VN Council for their three-year terms at the College’s AGM in July.
The College says it will only accept one question per person and questions must be decent.
Offensive, defamatory and inaccurate questions will not be passed on to candidates.
You can email your question to: vnvote24@rcvs.org.uk.
Virbac is offering its customers a discount on subscriptions to Vet Care Consult, an interactive veterinary medicine and anatomy tool designed to improve client understanding and aid compliance.
Vet Care Consult, designed by MediProductions with advice from veterinary specialists, uses more than 600 3D graphics, animations, videos and other imagery to help veterinary staff explain diagnoses and to discuss therapeutic options.
The veterinary surgeon or nurse selects the target species, then the relevant organ or system. A range of animations and videos are then offered to help explain their recommendation. The tool includes the option to email owners a link to a specific animation or video so that they can discuss the recommended treatment with family later. It can be used on a PC or tablet and is also available as an iPhone app.
A single user subscription normally costs £41 per month or £410 per annum.
Chris Geddes MRCVS, Senior Product Manager at Virbac, said: "Gone are the days of scribbling diagrams on scraps of paper and whiteboards or pointing to a model of a stifle that has seen better days!
"Vet Care Consult harnesses the latest technology to help the veterinary team communicate more effectively with clients, helping them to understand their pets' health and wellness issues. Better communication leads to improved compliance which, in turn, helps to strengthen the vital bond between a practice and its clients."
For more information, contact your Virbac Territory Manager.
The app allows practices to submit results along with cytology and histopathology results in order to help train the AI algorithm and improve its accuracy from an original sensitivity of 85% and negative predictive value of 97%.
Liron Levy-Hirsch, Managing Director of HT Vista, said: “The HT app has provided us with over 700 additional validated scans to analyse this year alone.
"The validation process is well controlled, whereby we use the lab results to tag the scans as benign or malignant and let the algorithm know if it was correct or not.
"The more we train the algorithm the more accurate it becomes, and it is extremely exciting to see the sensitivity increase to 90% and the NPV to 98%.”
HT Vista says the app was developed to meet demand from clinics.
Liron said: "By having a portal to upload lab results alongside the device’s results not only do we further improve the device, but we also increase confidence among our vets and nurses that the device is a reliable tool.
https://ht-vista.uk
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
References
The WSAVA's Global Nutrition Committee (GNC) has launched a Nutrition Toolkit for veterinary professionals.
The non-branded toolkit contains the following materials:
The toolkit is available for download at http://wsava.org/nutrition-toolkit.
Based on its importance to overall health, the WSAVA is campaigning to have a nutritional assessment confirmed as the fifth vital assessment in a standard physical examination and for the veterinary healthcare team to provide nutritional recommendations for each animal as an integral component of patient care.
The launch of the Nutrition Toolkit follows on from the Global Nutrition Committee's first initiative, the creation of a set of Nutrition Guidelines in 2011. These were aimed at helping veterinary professionals and pet owners ensure that pets are fed according to an optimal and individually tailored nutrition plan. According to WSAVA, they have been successful, securing endorsements from 19 veterinary organizations in 16 countries. They have been translated into ten languages and are available for download at http://www.wsava.org/guidelines/global-nutrition-guidelines.
GNC Co-Chair Dr Marge Chandler said: "Research shows that more than 90% of pet owners would like nutritional advice but fewer than 15% feel they receive it. In some parts of the world, pet malnutrition remains a major challenge, while in many other countries, pet obesity is an increasing problem. In addition, there is confusion about optimal nutrition because there is now so much conflicting and inaccurate information available online.
Our Nutrition Toolkit is designed to help the veterinary healthcare team address nutrition at every patient visit and to advance the central role of the veterinary healthcare team as the expert source of nutrition information."
Owners of hyperthyroid cats say they would rather veterinary surgeons prescribed the appropriate dosage for their pets than have an easy way to administer the medicine, according to new research carried out by feline expert Dr Sarah Caney BVSc PhD DSAM (Feline) MRCVS.
111 cat owners were questioned for the research, which was supported by Dechra Veterinary Products and has been accepted for publication in the Journal of Feline Medicine and Surgery.
Dechra says the results of the study challenge long-held perceptions, and should encourage a reappraisal of the approach to oral anti-thyroid medication:
89% of cat owners agreed with the statement that it 'was more important to me that the vet prescribes the most appropriate dose for my cat than that they provide me with an easy method of administering the medicine.'
Dr Caney said: "The survey has shown that cat owners are not a barrier to prescribing twice daily medication. Their overwhelming drive is to provide the best level of care that they can.
"From an owner perspective, the ideal anti-thyroid medication offers low doses and a variety of dosing strategies to ensure that each individual cat receives the dose they need and no more."
The findings revealed that 'once daily treatment' was not ranked as the most important statement on dosing by any of the owners and that only 21% of owners who had experienced oral dosing of their cat described the process as either 'tricky' or 'very difficult'.
Craig Sankey, Brand Manager for Felimazole at Dechra Veterinary Products, said: "We are very pleased to have supported such an important piece of independent research relating to feline hyperthyroidism which challenges some of the assumptions made about owner needs.
"Ease of administering the medicine is not the overwhelming issue for owners of cats with hyperthyroidism - administering the correct dose is. In fact, 79 % of cat owners questioned were happy to give pills twice a day if necessary."
To see the latest research in full, please visit www.dechra.co.uk/hyperthyroidism
The Client Care Hub, which is thought to be an industry-first, aims to provide CVS's 1,100 receptionists – and other colleagues who look after clients in CVS’ practices, crematoria and laboratories – with a solid foundation in all aspects of good client care.
The training hub offers a range of live and on-demand courses, including short courses, guides, webinars, in-depth courses and a Level 4 certificate programme.
Courses cover various aspects of client care, such as handling challenging conversations, triaging cases, diary management, finance, and personal wellbeing.
Some course content, designed by CVS’ in-house team in collaboration with receptionists and practice managers, is unique to the veterinary profession.
Philip Webb, Learning Partner at CVS Group, said: "We hope the quality of training we’re offering, along with the peer support network we’re facilitating, will make our colleagues’ day-to-day life even more rewarding and will longer-term serve to develop their careers.”
https://knowledgehub.cvsukltd.co.uk
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
Invicta Animal Health has launched EthyCalm Spray, a cryoanalgesic for minor procedures.
The active ingredient, ethyl chloride, acts as a local analgesic (pain relief) when sprayed or wiped onto the skin.
According to the company, the product is effective in a few seconds and works for a few minutes until the skin warms up again. This makes it suitable for such things as venepuncture, tick removal or placing of PVC's, where it should help reduce stress for the patient and the practitioner.
Ethycalm is presented in a 50ml vial which provides up to 100 applications.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to launch EthyCalm. During theatre training sessions for our product, ChloraPrep, we realised that the busy nurse doesn't have time to use traditional analgesia methods such as creams. They needed something instant yet cost-effective. Seeing the widespread use of ethyl chloride in places like Great Ormond Street Hospital, it was obvious that this product needed to be made available to veterinary practices".
For further information see www.invictavet.com or phone 01403 791313
Bayer Animal Health has announced the launch of a new campaign which plays on our anthropomorphic nature to drive owners into practice for worming.
As part of the campaign, the company has enrolled the behaviour specialist and author Sarah Whitehead to oversee a video analysis of the behavioural interaction between a small number of dogs and their owners. The results will be used to make an educational film for pet owners which helps them better understand their pet's emotions and behaviour.
Tracey Dawson, Group Product Manager at Bayer Animal Health said: "We want owners to really understand the importance of health on their dog's happiness and behaviour, whilst reminding them to worm their pet at least four times a year. Our ground breaking research will make owners feel like real-life Dr Doolittle, as they will better understand their pet's emotions and actions, highlighting the importance of keeping their dogs healthy, happy and worm-free."
In order to prompt owners to worm their dog more frequently, Bayer has also launched a free SMS/email worming reminder service available at www.drontal.com. In addition, there'll be a new CPD section for SQPs on the website in the summer..
Bayer is also developing 'Worm Reminder' toolkits for veterinary practices, including a press release template, infographics, and video report of the research findings to further promote the importance of worming frequently. For more information, talk to your Bayer representative.
Jon Bowen, animal behaviour consultant at the Royal Veterinary College and Sureflap have declared 8th May 'Vet Cat Watch Day', and are asking the profession to record the reason why each cat seen that day is brought into the practice.
Jon explained: "There are more than 10 million pet cats in the UK, however there is little information about the prevalence of injuries, disease, cat fights and road traffic accidents on a national scale".
The absence of data became apparent when findings from research on over 1,000 cats - conducted as part of the Neighbourhood Cat Campaign, supported by SureFlap and Your Cat magazine - revealed cats that had suffered minor injuries from fights were more likely to develop other health issues, such as hair loss and eye infections.
Judith Bank from SureFlap said: "People often purchase a microchip-operated cat flap to help their pet to feel secure. Owners tell us that their pet is spraying in the house or has been losing fur and this motivated us to support research to look deeper into the problems that pet owners might be having. We soon realised that objective data from vets was not available to qualify the findings and this is where the idea of 'Vet Cat Watch Day' emerged."
Jon said: "The aim of Vet Cat Watch Day is to take a snap-shot of cats' health from veterinary practices across the nation, on one day. The results will be compiled alongside information from cat owners gained in 'Cat Watch Day' a few days earlier.
A report detailing preliminary findings from the Neighbourhood Cat Campaign is available from the SureFlap website. When complete the results will be used to help provide vets with an insight into the lives of domestic cats so they are better equipped to understand behavioural issues.
For more information on Vet Cat Watch Day please visit the SureFlap website The site hosts a PDF to print out and help record the feline cases that come through practice doors on the 8th May, which can be downloaded from www.sureflap.co.uk/vetwatch_info. At the end of the day, visit www.sureflap.co.uk/vetwatch to upload your data to the online survey.
Elanco Companion Animal Health has launched Recuvyra 50mg/ml transdermal solution for dogs, the first transdermal fentanyl solution to be licensed for the control of postoperative pain associated with major orthopaedic and soft tissue surgery.
Recuvyra is a schedule two controlled drug which contains fentanyl, a pure μ-agonist synthetic opioid with a potency 100 times that of morphine1. Applied to the area between the shoulder blades by a needleless two-pronged adapter two to four hours prior to surgery, Elanco says Recuvyra provides at least four days of opioid analgesia, which is mainly due to the activation of the μ-opioid receptors inhibiting the perception of pain and the transmission of pain signals in the spinal cord and dorsal horn2.
Elanco says Recuvyra's unique formulation provides long-lasting analgesia by establishing a depot of fentanyl within the stratum corneum. The fentanyl in this depot undergoes passive diffusion down a concentration gradient, and is steadily released into the general circulation over a number of days.
Ed Whittle MA VetMB MRCVS, technical consultant at Elanco said: "Fentanyl is widely used in human health and its powerful analgesic properties are well known amongst veterinary surgeons1, 3, 4. Recuvyra is a ground-breaking veterinary product that will provide long-acting post-operative pain control in dogs while reducing the need for repeated, invasive administration of analgesics in the practice and improved client compliance and the potential for mutimodal analgesia once a dog returns home."
To ensure proper use of Recuvyra, Elanco has produced a mandatory online training programme for veterinary surgeons to complete before ordering the product. The brief online training module, which can be viewed at www.recuvyratraining.eu, features information on the presentation, correct preparation and administration of the product, and the safe handling of patients that have been treated with Recuvyra. Once veterinary surgeons are trained, it is their responsibility to train their staff on the in-practice use of Recuvyra and Elanco has produced a training presentation to help educate veterinary professionals about the product.
To support the launch of Recuvyra, Elanco has produced a dosing calculator, cage cards and client information sheet. For further information on Recuvyra, please contact your Elanco Companion Animal Health key account manager or email elancocah.uk@elanco.com.
The RCVS has appointed Nicola South to the new role of Customer Experience Manager, a new role intended to help improve the experience for vets, veterinary nurses and the public in their dealings with the College.
Nicola said: "I'm extremely excited and proud to be joining the staff at the RCVS, and at such a significant time, just as the First-Rate Regulator initiative is underway, which will lead to a change of focus in how we deliver our services to meet all of our customers' needs. My arrival has been met by a staff made up of extremely dedicated and passionate individuals, and I'm really looking forward to working as a team to deliver an improved customer experience for everyone."
CEO Nick Stace said: "Nicola brings to the College a wealth of customer service experience gained from the hotel and tourism industries. Improving our customer service delivery is a priority, and I am delighted to have Nicola on board who will help to champion these improvements across the organisation."
Nicola joins the RCVS from Orbit Group Ltd, where she was Service Excellence Advisor for the East and South Region.